CVS Health Stock News

DDD, ASO and CVS have been added to the Zacks Rank #5 (Strong Sell) List on May 6, 2024.

Prudential Financial has earned its reputation as a rock-solid insurer. Berkshire Hathaway has shown itself as a master of investing the float.

A Florida man has sued Publix, CVS Pharmacy and Costco pharmacies and their respective pharmacists after he says he was prescribed Adderall that sent him into psychosis.

CVS Health reported dismal earnings on May 1st, substantially dropping the stock price, resulting in the largest one-day drop on record. While revenues nearly met consensus expectations, current quart

Above-average utilization of health benefits pressured CVS Health's bottom line, but this is a temporary problem. Ares Capital is a business development company that offers a huge dividend yield at re

Shares in the drug chain and health insurer lost 19% after missing earnings and slashing guidance. The culprit: Costs for its Medicare Advantage plans.

CVS Health (NYSE: CVS) recently reported its Q1 results, with revenues and earnings missing our estimates. The company reported revenue of $88.4 billion and adjusted earnings of $1.31 per share, much

Earnings season presents buying opportunities for stocks that have experienced a dip in price after reporting Q1 earnings. Enterprise Products Partners offers a 7% yield and has strong fundamentals, i

CVS Health Corp (NYSE:CVS) copped a downgrade from buy to neutral from UBS today after the US pharmacy chain downwardly revised its full-year profit 2024 guidance amid rising medical costs in its Medi

Major U.S. equities indexes were mixed as the Federal Open Market Committee (FOMC) wrapped up its latest policy meeting, announcing it would maintain the federal funds rate at the decades-long high wh

The volatile consumer healthcare sector showed up big in CVS' Q1 earnings Wednesday (May 1), with solid revenue from its store operations but a warning about revenue projections due to its foray into

Walmart Inc. WMT, -0.43% announced Tuesday it's closing its 51 health centers after the retail giant admitted the business had not seen sustainable profits since its inception in 2019.

CVS Health Corp (NYSE:CVS) shares tanked after the pharmacy chain downwardly revised its full-year profit 2024 guidance amid rising medical costs in its Medicare insurance business.   The company is

CVS faced higher-than-expected costs in its insurance business. Lower Medicare Advantage reimbursement rates are expected to weigh on its performance.

CVS Health's (CVS) Q1 performance is impacted by a decline in the Health Services segment due to continued pharmacy client price improvements.